DocDollars

Novocure GMBH

Switzerland · Reporting entity ID 100000971857

Total reported 2019–2025
$17.6M
#351 of 2,960 reporting companies — 0% of all reported industry payments
$399K in general payments across 363 records, plus $17.2M in research funding across 2,334 records.

How it breaks down

General payments $399,241
Research funding $17,205,675

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Novocure GMBH reported $17.6M to US doctors and teaching hospitals from 2019 to 2025, ranking #351 of 2,960 reporting companies. 98% of that was research funding and 2% general payments such as consulting, speaking, food and travel. 363 general payment records and 2,334 research records were filed.

Common questions about Novocure GMBH

How much has Novocure GMBH paid US doctors?

Novocure GMBH reported $17,604,917 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $399,241 in general payments, $17,205,675 in research funding.

How does Novocure GMBH rank among drug and device companies?

It ranks #351 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Novocure GMBH mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.